中金:中國人壽業績好於市場預期 升AH股目標價分別至52元及30港元
中國人壽(2628.HK)發佈2020年半年度報告,實現營業收入5137.35億元,同比增長12.4%;歸屬於母公司股東的淨利潤305.35億元,同比下降18.8%。
中金髮表報告表示,中國人壽上半年業績好於市場預期,新業務價值按年增長7%,較市場預期高2%,該行將其H股目標價上調3%至30港元,而A股目標價上調6%至52元人民幣。
中金指,儘管行業不景氣,但公司代理人和員工數量仍然在增加,這將對公司下半年及明年的增長形成支持。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.